This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 Jun;64(6):857-8.

doi: 10.1136/gutjnl-2015-309464. Epub 2015 Mar 24.

Failure of interleukin 13 blockade in ulcerative colitis

Herbert Tilg¹, Arthur Kaser²

Affiliations

Affiliations

¹ Department of Internal Medicine I, Gastroenterology, Endocrinology & Metabolism, Medical University Innsbruck, Innsbruck, Austria.
² Division of Gastroenterology and Hepatology, Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.

PMID: 25804632
DOI: 10.1136/gutjnl-2015-309464

Comment

Failure of interleukin 13 blockade in ulcerative colitis

Herbert Tilg et al. Gut. 2015 Jun.

. 2015 Jun;64(6):857-8.

doi: 10.1136/gutjnl-2015-309464. Epub 2015 Mar 24.

Authors

Herbert Tilg¹, Arthur Kaser²

Affiliations

¹ Department of Internal Medicine I, Gastroenterology, Endocrinology & Metabolism, Medical University Innsbruck, Innsbruck, Austria.
² Division of Gastroenterology and Hepatology, Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.

PMID: 25804632
DOI: 10.1136/gutjnl-2015-309464

No abstract available

Keywords: ULCERATIVE COLITIS.

PubMed Disclaimer

Comment on

Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomised multicentre study.
Reinisch W, Panés J, Khurana S, Toth G, Hua F, Comer GM, Hinz M, Page K, O'Toole M, Moorehead TM, Zhu H, Sun Y, Cataldi F. Reinisch W, et al. Gut. 2015 Jun;64(6):894-900. doi: 10.1136/gutjnl-2014-308337. Epub 2015 Jan 7. Gut. 2015. PMID: 25567115 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information